| Dr Chris Frank Campana, MD | |
|
360 E 4500 S Ste 4, Salt Lake City, UT 84107-4297 | |
| (801) 266-0055 | |
| (801) 266-0056 |
| Full Name | Dr Chris Frank Campana |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 360 E 4500 S Ste 4, Salt Lake City, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114996675 | NPI | - | NPPES |
| 870326048001D3481 | Medicaid | UT | |
| D3481 | Medicaid | UT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZC0500X | Pathology - Cytopathology | 187346-1205 (Utah) | Secondary |
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 187346-1205 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Chris Frank Campana, MD Po Box 30309, Charleston, SC 29417-0309 Ph: (843) 284-3400 | Dr Chris Frank Campana, MD 360 E 4500 S Ste 4, Salt Lake City, UT 84107-4297 Ph: (801) 266-0055 |
News Archive
Colorectal cancer is the third most common cancer worldwide and the third-leading cause of cancer-related deaths. The main cause of death in patients with colorectal cancer is liver metastasis, with nearly 70% of patients eventually developing a liver tumor.
Damage caused by cerebral ischemia in premature babies could be reversed or prevented with early intervention, suggests research carried out in sheep and published in Science Translational Medicine.
Finding ways to help patients with COPD improve their functional status is an area of interest for pulmonary healthcare providers. Currently, pulmonary rehabilitation (PR) is used where available to improve exercise capacity and quality of life, but the treatment requires access to trained staff and specialized facilities.
A drug widely used to treat seizures and anxiety appears to be an effective treatment for restless legs syndrome (RLS) and helps people with the disorder get a better night's sleep, according to a study that will be presented as part of the Late-breaking Science Program at the American Academy of Neurology's 61st Annual Meeting in Seattle.
Palatin Technologies, Inc. today announced that a second phase I clinical trial of AZD2820, a subcutaneously-administered peptide melanocortin receptor partial agonist under development for the treatment of obesity, has commenced.
› Verified 2 days ago
Dr. Bryce J. Parkinson, DO, MBA Pathology Medicare: Not Enrolled in Medicare Practice Location: 15 N Medical Dr Ste 1100, Salt Lake City, UT 84112 Phone: 801-581-2121 | |
Yahya Daneshbod, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 15 N Medical Dr Ste 1100, Salt Lake City, UT 84112 Phone: 801-581-2121 | |
Robert E. Rogers, MD, PHD Pathology Medicare: Not Enrolled in Medicare Practice Location: Eccles Insititute Of Human Genetics: 15 N Medical Dr., Salt Lake City, UT 84112 Phone: 801-581-2121 | |
Dr. Melissa Hankins Cessna, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 8th Avenue & C Street, Salt Lake City, UT 84143 Phone: 801-408-1784 Fax: 801-408-5196 | |
Kajsa Elizabeth Affolter, Pathology Medicare: Accepting Medicare Assignments Practice Location: University Of Utah Hospital, 50 North Medical Drive, Salt Lake City, UT 84132 Phone: 801-581-2507 | |
David R. Anderson, DO Pathology Medicare: Not Enrolled in Medicare Practice Location: Eccles Insititute Of Human Genetics: 15 N Medical Dr., Salt Lake City, UT 84112 Phone: 801-581-2121 | |
Peter E. Jensen, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2507 |